Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Faroogh Marofi(Tabriz University of Medical Sciences), Mostafa Jarahian(Tabriz University of Medical Sciences), Navid Shomali(German Cancer Research Center), Walid Kamal Abdelbasset(Prince Sattam Bin Abdulaziz University), Abduladheem Turki Jalil(Alsalam University College), Ali Hassanzadeh(Iran University of Medical Sciences), Safa Tahmasebi(German Cancer Research Center), Hossein Saeedi(Tabriz University of Medical Sciences), Zaid Al-Obaidi(University of Alkafeel), Yashwant Pathak(Florida Southern College), Majid Ahmadi(Tabriz University of Medical Sciences), Wanich Suksatan(Chulabhorn Hospital), Max Stanley Chartrand, Heshu Sulaiman Rahman(University of Sulaimani), Behzad Baradaran(Tabriz University of Medical Sciences), A. E. Dorofeev(Sechenov University)
Cited by 132
Related Papers
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
|Frontiers in Pharmacology|2018|1.1k
CAR T cells in solid tumors: challenges and opportunities
|Stem Cell Research & Therapy|2021|573
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275
RETRACTED ARTICLE: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
|Journal of Translational Medicine|2021|204
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
|Frontiers in Immunology|2023|192